期刊文献+

Exendin-4的研究进展 被引量:1

Research Progress on Exendin-4
下载PDF
导出
摘要 在介绍Exendin-4的基础上,综述了目前最新的Exenatide用于治疗糖尿病的研究进展,并基于大量临床前数据,阐释了其功能、作用机制和毒理学研究。 On the basis of introducing Exendin-4, research progress of the latest Exenatide for curing diabete was summarized, on the basis of preclinical data, function, mechanism and toxicology were studied.
作者 吴海生
出处 《安徽农业科学》 CAS 2013年第13期5740-5742,共3页 Journal of Anhui Agricultural Sciences
关键词 EXENDIN-4 GLP-1 GLP-1受体 EXENATIDE Exendin-4 GLP-1 GLP-1 receptor Exenatide
  • 相关文献

参考文献20

  • 1DUNGAN K,BUSE J B.Glucagon-like peptide 1-based therapies for typeⅡdiabetes:A focus on Exenatide[J].Clin Diabet,2005,23(2):56-62.
  • 2HOIST J J,VIISBOLL T,DEACON C F. The increfin system and its role in type 2 diabetes [ J ]. Mol Cell Endocrino1,2009,297 :127 - 136.
  • 3NAUCK M A,HEIMESAAT M M,RSKOV C,et al.Preserved incretin ac-tivity of glucagon-like peptide 1[7-36 amide]but not of synthetic humangastric inhibitory polypeptide in patients with type-2 diabetes mellitus[J].J Clin Invest,1993,91:301-307.
  • 4NAUCK M A,NIEDEREICH-HOLZ U,ETTLER R,et al.Glucagon-likepeptide 1 inhibition of gastric emptying outweighs its insulinotropic effectsin healthy humans[J].Am J Physiol,1997,273:981-988.
  • 5ENG J,KLEINMAN W A,SINGH L,et al.Isolation and characterization ofExendin-4,an Exendin-3 analogue from Heloderma suspectum venom[J].JBiol Chem,1992,267:7402-7405.
  • 6KIEFFER T J,MCINTOSH C H,PEDERSON R A.Degradation of glucose-dependent insulinotropic polypeptide and truncated glucagon-like peptide-1in vitro and in vivo by dipeptidyl peptidase IV[J].Endocrinol,1995,136:3585-3596.
  • 7BAN K,NOYAN-ASHRAF M H,HOEFER J,et al.Cardioprotective andvasodilatory actions of glucagon-like peptide 1 receptor are mediatedthrough both glucagon-like peptide-1 receptor dependent and independentpathways[J].Circulation,2008,117:2340-2350.
  • 8MELONI A R,DEYOUNG M B,LOWE C,et al.GLP-1 receptor activatedinsulin secretion from pancreatic beta-cells:mechanism and glucose-de-pendence[J].Diab Obes Metab,2013,15(1):15-27.
  • 9NIELSEN L L,YOUNG A A,PARKES D G.Pharmacology of Exenatide(synthetic Exendin-4):a potential therapeutic for improved glycemic con-trol of type 2 diabetes[J].Reg Pept,2004,117:77-88.
  • 10ANDERSEN N H,BRODSKY Y,NEIDIGH J W,et al.Medium-depend-ence of the secondary structure of Exendin-4 and glucagon-like-peptide-1[J].Bioorg Med Chem,2002,10(1):79-85.

同被引文献3

引证文献1

二级引证文献2

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部